Sarobe P - Search Results

1

Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance.

de la Garza RG, Sarobe P, Merino J, Lasarte JJ, D'Avola D, Belsue V, Delgado JA, Silva L, Iñarrairaegui M, Sangro B, Sola JJ, Pardo F, Quiroga J, Herrero JI. de la Garza RG, et al. Among authors: sarobe p. Liver Transpl. 2013 Sep;19(9):937-44. doi: 10.1002/lt.23686. Epub 2013 Jul 26. Liver Transpl. 2013. PMID: 23784747 Free article. Clinical Trial.

2

Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct.

Lasarte JJ, Sarobe P, Gullón A, Prieto J, Borrás-Cuesta F. Lasarte JJ, et al. Among authors: sarobe p. Cell Immunol. 1992 Apr 15;141(1):211-8. doi: 10.1016/0008-8749(92)90140-k. Cell Immunol. 1992. PMID: 1532538 Free article.

3

Polarity of immunogens: implications for vaccine design.

Golvano J, Lasarte JJ, Sarobe P, Gullón A, Prieto J, Borrás-Cuesta F. Golvano J, et al. Among authors: sarobe p. Eur J Immunol. 1990 Oct;20(10):2363-6. doi: 10.1002/eji.1830201031. Eur J Immunol. 1990. PMID: 1700756

4

Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide.

Sarobe P, Lasarte JJ, Golvano J, Gullón A, Civeira MP, Prieto J, Borrás-Cuesta F. Sarobe P, et al. Eur J Immunol. 1991 Jun;21(6):1555-8. doi: 10.1002/eji.1830210633. Eur J Immunol. 1991. PMID: 1710570

5

Insights on the amino acid side-chain interactions of a synthetic T-cell determinant.

Borrás-Cuesta F, Golvano J, Sarobe P, Lasarte JJ, Prieto I, Szabo A, Guillaume JL, Guillet JG. Borrás-Cuesta F, et al. Among authors: sarobe p. Biologicals. 1991 Jul;19(3):187-90. doi: 10.1016/1045-1056(91)90033-g. Biologicals. 1991. PMID: 1719991

6

Overcoming class II-linked non-responsiveness to hepatitis B vaccine.

Hervás-Stubbs S, Berasain C, Golvano JJ, Lasarte JJ, Prieto I, Sarobe P, Prieto J, Borrás-Cuesta F. Hervás-Stubbs S, et al. Among authors: sarobe p. Vaccine. 1994 Aug;12(10):867-71. doi: 10.1016/0264-410x(94)90026-4. Vaccine. 1994. PMID: 7526566 Free article.

7

In vivo cytotoxic T-lymphocyte induction may take place via CD8 T helper lymphocytes.

Lasarte JJ, Sarobe P, Prieto J, Borrás-Cuesta F. Lasarte JJ, et al. Among authors: sarobe p. Res Immunol. 1995 Jan;146(1):35-44. doi: 10.1016/0923-2494(96)80238-0. Res Immunol. 1995. PMID: 7569311 Free article.

8

Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells.

Sarobe P, Lasarte JJ, Larrea E, Golvano JJ, Prieto I, Gullón A, Prieto J, Borrás-Cuesta F. Sarobe P, et al. Res Immunol. 1993 May;144(4):257-62. doi: 10.1016/0923-2494(93)80102-5. Res Immunol. 1993. PMID: 7690980 Free article.

9

Simple strategy to induce antibodies of distinct specificity: application to the mapping of gp120 and inhibition of HIV-1 infectivity.

Prieto I, Hervás-Stubbs S, García-Granero M, Berasain C, Riezu-Boj JI, Lasarte JJ, Sarobe P, Prieto J, Borrás-Cuesta F. Prieto I, et al. Among authors: sarobe p. Eur J Immunol. 1995 Apr;25(4):877-83. doi: 10.1002/eji.1830250403. Eur J Immunol. 1995. PMID: 7737288

10

Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr.

Sarobe P, Lasarte JJ, Golvano JJ, Prieto I, Gullón A, Soto MJ, Labarga P, Prieto J, Borrás-Cuesta F. Sarobe P, et al. J Acquir Immune Defic Syndr (1988). 1994 Jul;7(7):635-40. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8207641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters